Monitor Medpace's proposed judgment filing (due Dec 10, 2025) for the damages amount, which will determine the financial impact. The default judgment removes litigation risk for Medpace, but the stock may already reflect this win given the pre-filing investigation window. Watch for any appeal by defendants or settlement before judgment entry.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Dec 5 $548.12entry
- T+1 · 11mo ago +0.19%α +0.49% · $549.17
- T+5 · 11mo ago +1.78%α +2.36% · $557.90
- T+20 · 11mo ago +11.09%α +9.90% · $608.89
- T+60 · 9mo ago −14.37%α −14.02% · $469.38
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Medpace, Inc. obtained a default judgment against Agenus Inc. and Garo H. Armen in a breach-of-contract and breach-of-fiduciary-duty lawsuit after the defendants failed to comply with discovery obligations and did not oppose the sanctions motion. The court struck defendants' answers and granted default judgment, with Medpace to file a proposed judgment by December 10, 2025. This removes litigation uncertainty for Medpace and positions it to recover damages, though the amount has not yet been determined.
Court Ruling Details
Key Facts
- Medpace sued Agenus Inc. and Garo H. Armen for breach of contract and breach of fiduciary duty.
- Defendants engaged in 'wholesale noncompliance' with discovery obligations and failed to oppose the sanctions motion.
- Court granted default judgment, striking defendants' answers, on December 4, 2025.
- Medpace must file a proposed judgment by December 10, 2025; damages amount not yet specified in the opinion.
- The ruling is a final judgment on liability, with damages to be determined.
Financial Impact
Damages not yet quantified; Medpace to file proposed judgment by December 10, 2025.
Risk Factors
- Damages awarded may be below market expectations if the proposed judgment is modest.
- Defendants could appeal the default judgment, prolonging uncertainty.
- Agenus Inc. (AGEN) may face financial strain, but this is a separate ticker concern.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-24xutg8h-MEDP |
Track record
24 reports on MEDP
4 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +4.20% at T+5 after the Aug 25, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $652.28 Now $648.20 +0.62% settles Nov 17
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $653.94 to $648.20 Now $648.20 −0.88% ▼ −0.88% +1.03% vs SPY
- Nov 2, 202614d ago Insider Cluster Bearish 4/10 Entry $663.49 to $656.77 Now $648.20 +2.30% ▲ +1.01% +2.66% vs SPY
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $677.56 to $652.01 Now $648.20 −4.33% ▼ −3.77% −2.00% vs SPY
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 26, 202621d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $669.20 to $676.77 Now $648.20 −3.14% ▲ +1.13% +0.42% vs SPY
- Oct 21, 202626d ago 8-K Bullish 6/10 Entry $653.96 to $669.20 Now $648.20 −0.88% ▲ +2.33% +2.85% vs SPY
- Sep 28, 20267w ago SC 13D/A Neutral 4/10 Entry $622.11 to $624.18 Now $648.20 +4.19% ▲ +0.33% +0.54% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $583.21 to $593.02 Now $648.20 +11.14% ▲ +1.68% +1.24% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers